Susumu Nishio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Susumu Nishio has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Hirotsugu Yamada
Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
7 shared publications - Kenya Kusunose
Department of Cardiovascular Medicine, Nephrology, and Neurology, University of the Ryukyus, Okinawa, Japan
5 shared publications - Masataka Sata
Department of Cardiovascular Medicine, Tokushima University Hospital
3 shared publications - Tetsuzo Wakatsuki
Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima 770-8503, Japan
3 shared publications - Yukina Hirata
Ultrasound Examination Center, Tokushima University Hospital, Tokushima, Japan
3 shared publications Koji Yamaguchi
2 shared publications
Latest Publications
- Open Access
- 4 October 2017
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 9 (1) , 78
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
It is unknown whether canagliflozin, a selective sodium glucose co-transporter 2 inhibitor, reduces epicardial adipose tissue (EAT) thickness, which is associated with insulin resistance and is a risk factor for coronary artery disease. We administered 100 mg of canagliflozin for 6 months to 13 patients with type 2 diabetes mellitus. We evaluated glycemic control, visceral adipose tissue (VAT) area and subcutaneous adipose tissue (SAT) area, and skeletal muscle mass by using impedance methods, and EAT thickness by using echocardiography. Canagliflozin treatment for 6 months decreased hemoglobin A1c level from 7.1 ± 0.5% to 6.7 ± 0.6% (P < 0.05) and decreased EAT thickness from 9.3 ± 2.5 to 7.3 ± 2.0 mm (P < 0.001), along with a trend of decreasing VAT and SAT area. No association was found between any of these changes. Canagliflozin reduced EAT thickness in patients with type 2 diabetes mellitus independent of its effect on lowering blood glucose, suggesting that canagliflozin may have an effect in preventing cardiovascular events in these patients (UMIN000021327).
- 4 October 2017
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 9 (1) , 78
Open AccessCanagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
It is unknown whether canagliflozin, a selective sodium glucose co-transporter 2 inhibitor, reduces epicardial adipose tissue (EAT) thickness, which is associated with insulin resistance and is a risk factor for coronary artery disease. We administered 100 mg of canagliflozin for 6 months to 13 patients with type 2 diabetes mellitus. We evaluated glycemic control, visceral adipose tissue (VAT) area and subcutaneous adipose tissue (SAT) area, and skeletal muscle mass by using impedance methods, and EAT thickness by using echocardiography. Canagliflozin treatment for 6 months decreased hemoglobin A1c level from 7.1 ± 0.5% to 6.7 ± 0.6% (P < 0.05) and decreased EAT thickness from 9.3 ± 2.5 to 7.3 ± 2.0 mm (P < 0.001), along with a trend of decreasing VAT and SAT area. No association was found between any of these changes. Canagliflozin reduced EAT thickness in patients with type 2 diabetes mellitus independent of its effect on lowering blood glucose, suggesting that canagliflozin may have an effect in preventing cardiovascular events in these patients (UMIN000021327).
- 1 January 2016
- Published by Japan Society of Ultrasonics in Medicine in Choonpa Igaku
- Vol. 43 (4) , 581-586
Instantaneous Diagnosis of Infectious Endocarditis by Collaboration of Superficial and Ultrasound Examination and Echocardiography in a Patient with Mitral Valve Prolapse: Native Valve Endocarditis Caused by Staphylococcus Warneri
- 1 January 2016
- Published by Japan Society of Ultrasonics in Medicine in Choonpa Igaku
- Vol. 43 (4) , 581-586
Instantaneous Diagnosis of Infectious Endocarditis by Collaboration of Superficial and Ultrasound Examination and Echocardiography in a Patient with Mitral Valve Prolapse: Native Valve Endocarditis Caused by Staphylococcus Warneri
- 31 May 2013
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 41 (1) , 69-71
Massive tricuspid regurgitation due to pacemaker-lead puncture of the tricuspid valve: successful diagnosis by 3-dimensional echocardiography
- 31 May 2013
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 41 (1) , 69-71
Massive tricuspid regurgitation due to pacemaker-lead puncture of the tricuspid valve: successful diagnosis by 3-dimensional echocardiography
- 1 December 2011
- Vol. 59 (12) , 1099-106
[Management of the patient presenting chest pain].
A variety of diseases cause chest pain. Some entities such as acute coronary syndrome, aortic dissection, and pulmonary embolism are Life-threatening and immediate medical interventions may be required. Acute coronary syndrome is a disease due to disruption of plaque in coronary arteries. The echocardiography can be utilized to diagnose these situation by detecting wall motion abnormalities. Aortic dissection occurs when a tear in the inner wall of the aorta causes blood to flow between the layers of the wall and force the layers apart. The diagnosis can be made by pointing out the intimal flap by echocardiographic examination. A pulmonary embolism is a sudden blockage in a lung artery, which usually caused by a blood clot in a deep vein thrombosis. The echocardiography can prove the existence of pulmonary hypertension and right ventricular over loading. When one performs echocardiography in patients with chest pain in the emergency room, it is important to observe patient's condition, physical findings, and the electrocardiogram. The life-threatening diseases such as acute coronary syndrome, aortic dissection and pulmonary embolism should be considered in the first. If these lethal diseases are ruled out, every possibility including diseases other than cardiovascular disease must be considered. In the emergency echocardiography, incomplete knowledge and skills may lead misdiagnosis and patient's life is threatened. Thus, expert sonographer should perform the examination. The most important issue is to save the patients not to complete the echocardiographic study in this situation.
- 1 December 2011
- Vol. 59 (12) , 1099-106
[Management of the patient presenting chest pain].
A variety of diseases cause chest pain. Some entities such as acute coronary syndrome, aortic dissection, and pulmonary embolism are Life-threatening and immediate medical interventions may be required. Acute coronary syndrome is a disease due to disruption of plaque in coronary arteries. The echocardiography can be utilized to diagnose these situation by detecting wall motion abnormalities. Aortic dissection occurs when a tear in the inner wall of the aorta causes blood to flow between the layers of the wall and force the layers apart. The diagnosis can be made by pointing out the intimal flap by echocardiographic examination. A pulmonary embolism is a sudden blockage in a lung artery, which usually caused by a blood clot in a deep vein thrombosis. The echocardiography can prove the existence of pulmonary hypertension and right ventricular over loading. When one performs echocardiography in patients with chest pain in the emergency room, it is important to observe patient's condition, physical findings, and the electrocardiogram. The life-threatening diseases such as acute coronary syndrome, aortic dissection and pulmonary embolism should be considered in the first. If these lethal diseases are ruled out, every possibility including diseases other than cardiovascular disease must be considered. In the emergency echocardiography, incomplete knowledge and skills may lead misdiagnosis and patient's life is threatened. Thus, expert sonographer should perform the examination. The most important issue is to save the patients not to complete the echocardiographic study in this situation.
- 1 January 2011
- Vol. 53 (1) , 68-74
[Case of renal artery stenosis in an elderly patient after nephrectomy diagnosed by ultrasound sonography, showing improvement of blood pressure and renal dysfunction after renal artery stenting].
Arteriosclerotic renal artery stenosis is one of the increasingly common diseases that affects many aged patients. There are various non-invasive methods to diagnose renal artery stenosis, such as contrast enhanced CT or MRI. However, these methods are not appropriate for patients with renal dysfunction. Ultrasound sonography is becoming one of the promising methods to diagnose artery stenosis because of photographic improvements. In this case, a 72-year-old woman was hospitalized 7 months after nephrectomy because of severe hypertension, heart failure and kidney dysfunction. The heart failure was quite uncontrollable in spite of massive administration of diuretics, and finally, hemodialysis was started to control her volume status. In consideration of her past history and abdominal bruit, we evaluated the renal artery stenosis by ultrasound sonography and confirmed the diagnosis by renal angiography. To improve hypertension control, we performed renal artery stenting, which resulted in an impressive improvement of her blood pressure and renal function. We recognized the importance of careful causal evaluation of renal dysfunction, even though it is difficult to apply invasive therapy to patients after nephrectomy.
- 1 January 2011
- Vol. 53 (1) , 68-74
[Case of renal artery stenosis in an elderly patient after nephrectomy diagnosed by ultrasound sonography, showing improvement of blood pressure and renal dysfunction after renal artery stenting].
Arteriosclerotic renal artery stenosis is one of the increasingly common diseases that affects many aged patients. There are various non-invasive methods to diagnose renal artery stenosis, such as contrast enhanced CT or MRI. However, these methods are not appropriate for patients with renal dysfunction. Ultrasound sonography is becoming one of the promising methods to diagnose artery stenosis because of photographic improvements. In this case, a 72-year-old woman was hospitalized 7 months after nephrectomy because of severe hypertension, heart failure and kidney dysfunction. The heart failure was quite uncontrollable in spite of massive administration of diuretics, and finally, hemodialysis was started to control her volume status. In consideration of her past history and abdominal bruit, we evaluated the renal artery stenosis by ultrasound sonography and confirmed the diagnosis by renal angiography. To improve hypertension control, we performed renal artery stenting, which resulted in an impressive improvement of her blood pressure and renal function. We recognized the importance of careful causal evaluation of renal dysfunction, even though it is difficult to apply invasive therapy to patients after nephrectomy.
- 28 December 2008
- Published by Wiley in Echocardiography
- Vol. 26 (1) , 113
Continuing Medical Education Program inEchocardiography
- 28 December 2008
- Published by Wiley in Echocardiography
- Vol. 26 (1) , 113
Continuing Medical Education Program inEchocardiography